(Exact name of small business issuer as specified in its charter)
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
(Address of principal executive offices)
(Registrant's Telephone number)
(Former Name or Former Address, if Changed Since Last Report)
On July 14, 2011, QuantRx Biomedical Corporation (the "Company") issued a press release announcing its initial plans to bring to market its innovative patented diagnostic technologies, particularly its genomic-based diagnostic technology targeting the monitoring of recurring cancers and serious fetal genomic disease and health conditions. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. The press release corrects and replaces in full the press release issued by the Company, dated July 13, 2011.
See Exhibit Index.
QuantRx Biomedical Corporation |
By: | /s/ Dr. Shalom Hirschman |
Name: Dr. Shalom Hirschman | |
Title: Chief Executive Officer |
Exhibit No. | Description | |
EX-99.1 | Press Release, dated July 14, 2011 |